Longeveron (LGVN) Total Liabilities (2020 - 2026)

Longeveron (LGVN) recorded quarterly Total Liabilities of $5.2 million in Q1 2026, up 13.02% quarter-over-quarter from $4.6 million in Q4 2025, and up 40.46% on a YoY basis from $3.7 million in Q1 2025.

Longeveron (LGVN) Total Liabilities (2020 - 2026) Analysis & Trends

Longeveron's Total Liabilities history runs 7 years deep, the most recent figure standing at $5.2 million for Q1 2026.

  • In Q1 2026, Total Liabilities rose 40.46% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 40.46% YoY), while the FY2025 annual figure was $4.6 million, up 24.93% from the prior year.
  • Total Liabilities was $5.2 million for Q1 2026 at Longeveron, up from $4.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $6.9 million in Q4 2022 to a low of -$34.3 million in Q1 2022.
  • Historically, Total Liabilities has averaged -$1.0 million across 5 years, with a median of $4.6 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Total Liabilities soared 120.28% in 2023, then slumped 44.56% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $6.9 million in 2022, then dropped by 22.76% to $5.3 million in 2023, then plunged by 31.22% to $3.7 million in 2024, then grew by 24.93% to $4.6 million in 2025, then grew by 13.02% to $5.2 million in 2026.
  • The last three Total Liabilities figures came in at $5.2 million (Q1 2026), $4.6 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.74 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.48 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 731.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 10.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 19.51 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 943,068.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.12 Bn
9 Abivax 91.96 Bn 91.96 Bn - 137.56 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 5.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.18 Mn
Dec 31, 2025 4.59 Mn
Sep 30, 2025 5.59 Mn
Jun 30, 2025 4.09 Mn
Mar 31, 2025 3.69 Mn
Dec 31, 2024 3.67 Mn
Sep 30, 2024 4.28 Mn
Jun 30, 2024 4.48 Mn
Mar 31, 2024 6.66 Mn
Dec 31, 2023 5.34 Mn
Sep 30, 2023 4.99 Mn
Jun 30, 2023 5.83 Mn
Mar 31, 2023 5.49 Mn
Dec 31, 2022 6.91 Mn
Sep 30, 2022 -24.62 Mn
Jun 30, 2022 -29.38 Mn
Mar 31, 2022 -34.31 Mn
Dec 31, 2021 5.31 Mn
Dec 31, 2020 -1.96 Mn